Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation
Patrick Naumann, Jonathan Eberlein, Benjamin Farnia, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1655-1655
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

The Utility of Body Composition Assessment in Nutrition and Clinical Practice: An Overview of Current Methodology
Clifton J. Holmes, Susan B. Racette
Nutrients (2021) Vol. 13, Iss. 8, pp. 2493-2493
Open Access | Times Cited: 210
Disuse-induced skeletal muscle atrophy in disease and nondisease states in humans: mechanisms, prevention, and recovery strategies
Everson Araújo Nunes, Tanner Stokes, James McKendry, et al.
AJP Cell Physiology (2022) Vol. 322, Iss. 6, pp. C1068-C1084
Open Access | Times Cited: 96
Phenotypic features of cancer cachexia‐related loss of skeletal muscle mass and function: lessons from human and animal studies
Agnès Martin, Damien Freyssenet
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 2, pp. 252-273
Open Access | Times Cited: 64
Adiposity and cancer survival: a systematic review and meta-analysis
En Cheng, Jocelyn Kirley, Elizabeth M. Cespedes Feliciano, et al.
Cancer Causes & Control (2022) Vol. 33, Iss. 10, pp. 1219-1246
Open Access | Times Cited: 38
Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta‐analysis
Daniel de la Iglesia, Bartu Avci, Mariia Kiriukova, et al.
United European Gastroenterology Journal (2020) Vol. 8, Iss. 9, pp. 1115-1125
Open Access | Times Cited: 66
Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform
Ashok Narasimhan, Safi Shahda, Joshua K. Kays, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3787-3787
Open Access | Times Cited: 39
Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer
Emmanuel Salinas-Miranda, Dominik Deniffel, Xin Dong, et al.
European Radiology (2021) Vol. 31, Iss. 11, pp. 8662-8670
Closed Access | Times Cited: 33
The impact of chemotherapy on adipose tissue remodeling: The molecular players involved in this tissue wasting
Samuel Barbosa, Mafalda Barbosa Pedrosa, Rita Ferreira, et al.
Biochimie (2024) Vol. 223, pp. 1-12
Open Access | Times Cited: 5
Sarcopenia and Systemic Inflammation Synergistically Impact Survival in Oral Cavity Cancer
Jie Lee, Shih‐Hua Liu, Kun‐Yao Dai, et al.
The Laryngoscope (2020) Vol. 131, Iss. 5
Closed Access | Times Cited: 38
The impact of inflammation and acute phase activation in cancer cachexia
Tyler P. Robinson, Tewfik Hamidi, Brittany R. Counts, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
One-Year Mortality in Patients with Cancer Cachexia: Association with Albumin and Total Protein
Xiaoyue Liu, Xi Zhang, Guo‐Tian Ruan, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 6775-6783
Open Access | Times Cited: 26
The Differential Clinical Impacts of Cachexia and Sarcopenia on the Prognosis of Advanced Pancreatic Cancer
Ya‐Chin Hou, Chien‐Yu Chen, Chien‐Jui Huang, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3137-3137
Open Access | Times Cited: 17
Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Anish J. Jain, Jessica Maxwell, Matthew H. G. Katz, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4174-4174
Open Access | Times Cited: 10
Body composition parameters predict survival in pancreatic cancer—A retrospective multicenter analysis
Marko Damm, Ljupcho Efremov, Mustafa Jalal, et al.
United European Gastroenterology Journal (2023) Vol. 11, Iss. 10, pp. 998-1009
Open Access | Times Cited: 10
Pancreatic cancer: branched-chain amino acids as putative key metabolic regulators?
Lenka Rossmeislová, Jan Gojda, Katarína Smolková
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 4, pp. 1115-1139
Closed Access | Times Cited: 22
Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer
Oki Nakano, Hirokazu Kawai, Takamasa Kobayashi, et al.
Cancer Medicine (2021) Vol. 10, Iss. 13, pp. 4291-4301
Open Access | Times Cited: 21
Associations of Overall Survival with Geriatric Nutritional Risk Index in Patients with Advanced Pancreatic Cancer
Christina Grinstead, Thomas J. George, Bo Han, et al.
Nutrients (2022) Vol. 14, Iss. 18, pp. 3800-3800
Open Access | Times Cited: 15
Muscle Loss During Androgen Deprivation Therapy Is Associated With Higher Risk of Non-Cancer Mortality in High-Risk Prostate Cancer
Pai-Kai Chiang, Wei-Kung Tsai, Allen Wen-Hsiang Chiu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 19
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma
Ilaria Trestini, Marco Cintoni, Emanuele Rinninella, et al.
World Journal of Gastrointestinal Surgery (2021) Vol. 13, Iss. 9, pp. 885-903
Open Access | Times Cited: 18
Deep learning–based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment
Sebastian Nowak, Christoph Kloth, Maike Theis, et al.
European Radiology (2023) Vol. 34, Iss. 1, pp. 279-286
Open Access | Times Cited: 7
Muscle and Adipose Wasting despite Disease Control: Unaddressed Side Effects of Palliative Chemotherapy for Pancreatic Cancer
Pamela Klassen, Vickie E. Baracos, Sunita Ghosh, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4368-4368
Open Access | Times Cited: 7
The mortality burden of cachexia or weight loss in patients with colorectal or pancreatic cancer: A systematic literature review
Richard F. Dunne, Jeffrey Crawford, Karen E. Smoyer, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 5, pp. 1628-1640
Open Access | Times Cited: 2
Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer
Jie Lee, Jhen‐Bin Lin, Meng‐Hao Wu, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 595-595
Open Access | Times Cited: 20
Management of diet in gastrointestinal cancer
Clare Shaw
Proceedings of The Nutrition Society (2020) Vol. 80, Iss. 1, pp. 65-72
Open Access | Times Cited: 20
The impact of nutritional status on pancreatic cancer therapy
Gabriele Capurso, Nicolò Pecorelli, Alice Burini, et al.
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 2, pp. 155-167
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top